Abstract
Antibiotic prophylaxis with cefuroxime can reduce the incidence of deep wound infection (DWI) in hip-fracture surgery, but may increase the risk of C. difficile infection (CDI). An alternative is gentamicin with beta-lactam for which a question exists around clinical effectiveness and safety, given the gentamicin-associated nephrotoxicity particularly in the elderly and narrower sensitivity spectrum. We compared 744 consecutive patients (group I—cefuroxime) with 756 in group II (gentamicin + flucloxacillin) who were well matched. There were 4 cases of CDI in the cefuroxime prophylaxis, whereas none in flucloxacillin plus gentamicin (group II). There was a statistically significant (p = 0.036) increased DWI rate in group II (2.5 %) as compared to group I (1.1 %). However, after controlling for age, gender, ASA grade, surgeon grade, implant type and type of anaesthesia, there was no statistically significant difference between the two groups (p = 0.146). 8.5 % of group I and 16.5 % of group II developed AKI post-operatively (p = 0.023); however, 79 % of group I and 80 % of in group II had complete resolution of AKI prior to their discharge. Further, a significant increase in inpatient deaths (p = 0.057) in group II was observed, but not at 30 days (p = 0.378).
Similar content being viewed by others
References
Marsh D et al (2007) The care of patients with fragility fractures. British Orthopaedic Association, London
White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 42(11):1230–1233
Chesser T et al (2011) The management of hip fracture in adults. National Clinical Guideline Centre, London
Falls Free: Promoting a National Falls Prevention Action Plan: Research Review Papers (2005) NCOA Centre for Healthy Aging, pp 3–18
BOAST 1: Hip fracture in older people, September 2007. http://www.boa.ac.uk. Last accessed 1 Aug 2013
SIGN Guidelines no. 104 “Antibiotics prophylaxis in surgery”—July 2008. http://www.sign.ac.uk/pdf/sign104.pdf. Last accessed 1 Aug 2013
Peel ALG, Taylor EW (1991) Proposed definitions for the audit of postoperative infection: a discussion paper. Ann RCS 73:385–388
Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90(6):770–777
Chiu K, Lau S, Fung B, Ng K, Chow S (1993) Plastic adhesive drapes and wound infection after hip fracture surgery. ANZ J Surg 63:798–801
Mackay DC, Harrison WJ, Bates JHJ, Dickendon D (2000) Audit of deep wound infection following hip fracture surgery. J R Coll Surg Edinb 45:56–59
SIGN Guidelines no. 111“Management of hip fracture in older people”—June 2009
National Clostridium difficile Standards Group (2004) Report to the Department of Health. J Hosp Infect 56:S1–S38
Clostrium difficile infection: how to deal with the problem, London, 2009. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1232006607827. Last accessed 1 Aug 2013
Dubberke ER, Reske KA, Yan Y et al (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543–1549
Davey P, Brown E, Fenelon L et al (2006) Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis 12:211–216
Wilcox MH, Freeman J, Fawley W et al (2004) Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 2004(54):168–172
Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995(130):989–993
Gilbert DN (2010) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Principle and practice of infectious diseases, 7th edn. Churchill Livingstone, New York, pp 307–336
Starks I, Ayub G, Walley G, Orendi J, Roberts P, Maffulli N (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70(1):21–26
Katzung BG (2001) Basic & clinical pharmacology. 9th Edition, lange medical books, vol 43. McGraw Hill, New York, pp 734–764
Mingeot-Leclerq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012
Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL (1999) Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 43:1549–1555
Selby MN, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin associated acute kidney injury. Q J Med 102:873–880
Patterson DL, Robson JM, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735–739
Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med 95:291–297
Baciewicz AM, Sokos DR, Cowan RI (2003) Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharm 37:182–186
Levey AS et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100
Craig RG, Hunter JM (2008) Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaes 101:296–310
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
National Hip Fracture Database National Report (2012) http://www.nhfd.co.uk/. Last accessed 12 Dec 2012
AlBuhairan B, Hind D, Hutchinson A (2008) Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 90:915–919
Scottish Antimicrobial Prescription Group: Antibiotic prophylaxis in surgery. http://www.scottishmedicines.org.uk/files/Microsoft_Word_-_SAPG_Guidance_on_surgical_prophylaxis.pdf. Last accessed 1 Aug 2013
Challagundla SR et al (2013) Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transpl 28:612–619
American Academy of Orthopaedic Surgeons. Information statement: recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty. http://www.aaos.org/about/papers/advistmt/1027.asp. Last accessed 1 Aug 2013
Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ (2008) Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 22:264–269
Starks I et al (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70:21–26
Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S (2010) Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br 92:994–998
Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39:650–655
Kumin GD (1980) Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA 244:1808–1810
Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P (1996) Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 40:2494–2499
Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37:645–663
Fujita K, Sayama T, Abe S, Murayama T, Tashiro H (1985) Age dependent aminoglycoside nephrotoxicity. J Urol 134:596–597
Moore RD, Smith CR, Lipski JJ, Mellits ED, Leitman PS (1984) Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352–357
Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of co-morbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374
Royal College of Physicians (2007) National clinical audit of falls and bone health in older people. November, 2007. http://old.rcplondon.ac.uk/clinical-standards/ceeu/Documents/fbhop-execsummary.pdf. Accessed 30 July 2013
White SM, Rashid N, Chakladar A (2009) An analysis of renal dysfunction in 1511 patients with fractured neck of femur: the implications for peri-operative analgesia. Anaesthesia 64:1061–1065
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmed, I., Khan, M.A., Allgar, V. et al. The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery. Eur J Orthop Surg Traumatol 26, 483–492 (2016). https://doi.org/10.1007/s00590-016-1794-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-016-1794-7